Facebook Twitter Linkedin NASDAQ Market NewsClick here to email authorNEXT STORYCRISPR Therapeutics and Vertex Announce New Clinical Data for Investigational Gene-Editing Therapy CTX001™ in Severe Hemoglobinopathies at the 25th Annual European Hematology Association (EHA) CongressPREV STORYVaxcyte Announces Pricing of Upsized Initial Public Offering